Cart
sales@molnova.com
ACBI3
CAS No. 2938169-76-5
ACBI3( —— )
Catalog No. M37580 CAS No. 2938169-76-5
ACBI3 (compound 7), a pan-KRAS degrader, effectively accomplishes the in vivo degradation of oncogenic KRAS .
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 1036 | In Stock |
|
| 5MG | 629 | In Stock |
|
| 10MG | 943 | In Stock |
|
| 25MG | 1606 | In Stock |
|
| 50MG | 2195 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameACBI3
-
NoteResearch use only, not for human use.
-
Brief DescriptionACBI3 (compound 7), a pan-KRAS degrader, effectively accomplishes the in vivo degradation of oncogenic KRAS .
-
DescriptionACBI3 (compound 7) is a pan-KRAS degrader. ACBI3 achieves in vivo degradation of oncogenic KRAS.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2938169-76-5
-
Formula Weight1019.25
-
Molecular FormulaC50H62N14O6S2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC[C@]1(C2=C(SC(N)=C2C#N)CCC1)C3=NC(=NO3)C4=NC(=NC=C4)N5[C@@H](C)CN(CCCCOC6=CN([C@H](C(=O)N7[C@H](C(N[C@@H](CO)C8=CC=C(C=C8)C=9SC=NC9C)=O)C[C@@H](O)C7)C(C)C)N=N6)CCC5
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Crocetin methylester
Crocetin monomethyl ester (Standard) is the analytical standard of Crocetin monomethyl ester. This product is intended for research and analytical applications. Crocetin monomethyl ester, isolated from Crocus sativus, possesses anti-inflammatory, neuroprotective and antioxidant activity. Crocetin monomethyl ester promotes clearance of amyloid-β by inducing autophagy via the STK11/LKB1-mediated AMPK pathway.
-
Concizumab
Concizumab is an anti-TFPI monoclonal antibody (IgG4 type) that selectively binds to the Kunitz protease inhibitor (KPI) 2 domain of TFPI, blocking its interaction with the FXa active site.
-
Thalidomide-O-amido-...
Thalidomide-O-amido-C6-NH2 hydrochloride is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker. It can be used in the synthesis of PROTACs.
